[KLK] YoY Annualized Quarter Result on 31-Mar-2013 [#2]

Announcement Date
22-May-2013
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2013
Quarter
31-Mar-2013 [#2]
Profit Trend
QoQ- -9.82%
YoY- -15.35%
View:
Show?
Annualized Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 16,080,720 12,359,172 10,856,390 9,113,014 11,094,762 9,582,674 7,298,034 14.05%
PBT 2,307,948 1,181,698 1,604,300 1,276,340 1,549,614 1,792,224 1,257,868 10.63%
Tax -272,698 -272,694 -325,124 -280,728 -372,718 -363,684 -290,226 -1.03%
NP 2,035,250 909,004 1,279,176 995,612 1,176,896 1,428,540 967,642 13.17%
-
NP to SH 1,927,484 873,480 1,214,578 941,152 1,111,786 1,356,080 915,508 13.19%
-
Tax Rate 11.82% 23.08% 20.27% 21.99% 24.05% 20.29% 23.07% -
Total Cost 14,045,470 11,450,168 9,577,214 8,117,402 9,917,866 8,154,134 6,330,392 14.19%
-
Net Worth 9,808,334 8,383,277 8,029,841 7,188,518 7,007,233 6,357,623 5,708,612 9.43%
Dividend
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Div 319,489 319,565 319,489 319,489 319,478 319,478 319,511 -0.00%
Div Payout % 16.58% 36.59% 26.30% 33.95% 28.74% 23.56% 34.90% -
Equity
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Net Worth 9,808,334 8,383,277 8,029,841 7,188,518 7,007,233 6,357,623 5,708,612 9.43%
NOSH 1,064,965 1,065,219 1,064,965 1,064,965 1,064,929 1,064,928 1,065,039 -0.00%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin 12.66% 7.35% 11.78% 10.93% 10.61% 14.91% 13.26% -
ROE 19.65% 10.42% 15.13% 13.09% 15.87% 21.33% 16.04% -
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
RPS 1,509.98 1,160.25 1,019.41 855.71 1,041.83 899.84 685.24 14.06%
EPS 181.00 82.00 114.00 88.40 104.40 127.34 85.96 13.20%
DPS 30.00 30.00 30.00 30.00 30.00 30.00 30.00 0.00%
NAPS 9.21 7.87 7.54 6.75 6.58 5.97 5.36 9.43%
Adjusted Per Share Value based on latest NOSH - 1,064,965
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
RPS 1,463.23 1,124.60 987.85 829.22 1,009.54 871.96 664.07 14.05%
EPS 175.39 79.48 110.52 85.64 101.16 123.39 83.30 13.19%
DPS 29.07 29.08 29.07 29.07 29.07 29.07 29.07 0.00%
NAPS 8.9249 7.6282 7.3066 6.541 6.3761 5.785 5.1944 9.43%
Price Multiplier on Financial Quarter End Date
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Date 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 31/03/11 31/03/10 -
Price 24.00 22.78 24.20 20.92 24.60 21.20 16.68 -
P/RPS 1.59 1.96 2.37 2.44 2.36 2.36 2.43 -6.81%
P/EPS 13.26 27.78 21.22 23.67 23.56 16.65 19.40 -6.13%
EY 7.54 3.60 4.71 4.22 4.24 6.01 5.15 6.55%
DY 1.25 1.32 1.24 1.43 1.22 1.42 1.80 -5.89%
P/NAPS 2.61 2.89 3.21 3.10 3.74 3.55 3.11 -2.87%
Price Multiplier on Announcement Date
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Date 16/05/16 20/05/15 21/05/14 22/05/13 24/05/12 25/05/11 26/05/10 -
Price 23.10 22.40 24.70 21.70 22.16 21.50 15.58 -
P/RPS 1.53 1.93 2.42 2.54 2.13 2.39 2.27 -6.35%
P/EPS 12.76 27.32 21.66 24.55 21.23 16.88 18.12 -5.67%
EY 7.84 3.66 4.62 4.07 4.71 5.92 5.52 6.01%
DY 1.30 1.34 1.21 1.38 1.35 1.40 1.93 -6.36%
P/NAPS 2.51 2.85 3.28 3.21 3.37 3.60 2.91 -2.43%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment